Fareva is a leading global pharmaceutical CDMO with a network of 16 manufacturing sites and 3 development sites throughout EMEA and the Americans. We offer comprehensive drug product and API services, including formulation development, clinical manufacturing, scale-up, and commercial manufacturing of small and large molecules. Our capabilities cover a wide range of dosage forms, such as OTC products, oral solid doses, non-sterile liquids and solids, ophthalmics, as well as sterile fill/finish and lyophilized presentations.
In addition, our facilities have extensive expertise in secondary packaging, enabling us to serve as a fully integrated partner for our clients’ end-to-end pharmaceutical needs.
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Primary business activity | Contract Manufacturer |
| Affiliated categories: | Dietary supplements |Pharma and OTC products More |